RGEN Q3 2022 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

Q3 2022 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$201M+12.6% YoY

Gross Profit

$114M56.9% margin

Operating Income

$53M26.2% margin

Net Income

$40M20.1% margin

EPS (Diluted)

$0.71

QoQ Revenue Growth

-3.3%

Cash Flow

Operating Cash Flow

$41M

Free Cash Flow

-$16M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$2.5B

Total Liabilities

$627M

Stockholders' Equity

$1.8B

Cash & Equivalents

$573M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$201M	$178M	+12.6%
Gross Profit	$114M	$103M	+11.2%
Operating Income	$53M	$45M	+16.5%
Net Income	$40M	$33M	+20.6%

Revenue Segments

Product

$201M100%

Royalty

$33,0000%